TheJobsMapAbout 89bio
Powerful ScienceMeaningful MedicinesChanging Lives 89bio is a clinical-stage biopharma company focused on the development and commercialization of innovative therapies for patients with non-alcoholic steatohepatitis (NASH), severe hypertrigly-ceridemia...
Founded in 2018 by Michael Hayden.
- Founded
- 2018
- Employees
- 11 to 50
- Total funding
- $773.2M
- Headquarters
- San Francisco
Leadership
The top of 89bio's org chart, with how many people report into each leader.
Quoc Le-Nguyen
Chief Technical Operations Officer & Head of Quality
19 reports
Francis Sarena
COO
12 reports
Hank Mansbach
Chief Medical Officer
10 reports
Ryan Martins
Chief Financial Officer
6 reports
Melissa Abel
SVP, Commercial Strategy
4 reports
Amanda Kurihara
VP, People & Culture
3 reports
Shaji Joseph
VP, CMC
7 reports
Michael Baldwin
VP & Head of Quality
5 reports
Shibao Feng
Head Of Biometrics
2 reports
Roger Lee
Executive Director / Head Of CMC Drug Product
1 report
Nancy Vinh
Senior Vice President, Clinical Operations
10 reports
Rotem Dror
Director, Business Operations And Operational Excellence
Toni Bransford
Vice President Of Clinical Development
3 reports
Wenyan Wang
Vice President, Clinical Develpment
1 report
Board
Steven Altschuler
Chairman
Kathy Laporte
Director
Lota Zoth
Director
Michael Hayden
Director
Derek Dirocco
Director
Charles A. McWherter
Director
Jobs at 89bio
No open positions right now. Explore more companies on TheJobsMap.